ArticleClinical and translational gastroenterology2022

Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies.

Brigid S Boland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.